These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27553747)

  • 1. Human papilloma virus vaccination and dysautonomia: Considerations for autoantibody evaluation and HLA typing.
    Hendrickson JE; Tormey CA
    Vaccine; 2016 Aug; 34(38):4468. PubMed ID: 27553747
    [No Abstract]   [Full Text] [Related]  

  • 2. Human papilloma virus vaccination in Nepal: an initial experience in Nepal.
    Singh Y; Shah A; Singh M; Verma S; Shrestha BM; Vaidya P; Nakarmi RP; Shrestha SB
    Asian Pac J Cancer Prev; 2010; 11(3):615-7. PubMed ID: 21039025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing human papilloma virus (HPV) vaccination uptake in people living with HIV: the need to improve both clinician training and health promotion.
    Ringshall M; Cable C; Fitzpatrick C; Richardson D
    Sex Transm Infect; 2022 Nov; 98(7):536. PubMed ID: 34716227
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage.
    Ekwunife OI; Lhachimi SK
    BMC Health Serv Res; 2017 Dec; 17(1):815. PubMed ID: 29216880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human papillomavirus infection and vaccination].
    He ZH; Kou ZQ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):106-112. PubMed ID: 29334719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination: A Double Opportunity to Prevent Human Papilloma Virus Infection].
    Chambel B
    Acta Med Port; 2020 Jun; 33(6):440. PubMed ID: 32504521
    [No Abstract]   [Full Text] [Related]  

  • 8. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HPV and cervical cancer].
    J Midwifery Womens Health; 2013; 58(2):245-6. PubMed ID: 23451858
    [No Abstract]   [Full Text] [Related]  

  • 10. Perceptions and opinions regarding human papilloma virus vaccination among young women in Malaysia.
    Al-Naggar RA; Al-Jashamy K; Chen R
    Asian Pac J Cancer Prev; 2010; 11(6):1515-21. PubMed ID: 21338190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How will HPV vaccines affect cervical cancer?
    Roden R; Wu TC
    Nat Rev Cancer; 2006 Oct; 6(10):753-63. PubMed ID: 16990853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of quadrivalent HPV vaccination on HPV related disease in women treated for cervical or vulvar/vaginal disease.
    Kim JJ
    BMJ; 2012 Mar; 344():e1544. PubMed ID: 22454090
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypothesis: Human papillomavirus vaccination syndrome--small fiber neuropathy and dysautonomia could be its underlying pathogenesis.
    Martínez-Lavín M
    Clin Rheumatol; 2015 Jul; 34(7):1165-9. PubMed ID: 25990003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of vaccines against human papillomavirus (HPV)].
    Prygiel M; Janaszek-Seydlitz W
    Przegl Epidemiol; 2012; 66(4):657-65. PubMed ID: 23484396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness of human papilloma virus and cervical cancer prevention among Greek female healthcare workers.
    Farazi PA; Hadji P; Roupa Z
    Eur J Cancer Prev; 2017 Jul; 26(4):330-335. PubMed ID: 27254169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma virus vaccine for low and middle income countries: A step too soon?
    Jindal HA; Kaur A; Murugan S
    Hum Vaccin Immunother; 2017 Nov; 13(11):2723-2725. PubMed ID: 28846491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge of cervical cancer and the HPV vaccine.
    Paniagua H
    Br J Nurs; 2006 Feb 9-22; 15(3):126-7. PubMed ID: 16493315
    [No Abstract]   [Full Text] [Related]  

  • 19. Greatest effect of HPV vaccination from school-based programmes.
    Regan DG; Hocking JS
    Lancet Infect Dis; 2015 May; 15(5):497-8. PubMed ID: 25744473
    [No Abstract]   [Full Text] [Related]  

  • 20. Challenges of implementing human papillomavirus (HPV) vaccination policy.
    Raffle AE
    BMJ; 2007 Aug; 335(7616):375-7. PubMed ID: 17717366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.